GB0610570D0 - Novel formulation - Google Patents

Novel formulation

Info

Publication number
GB0610570D0
GB0610570D0 GBGB0610570.4A GB0610570A GB0610570D0 GB 0610570 D0 GB0610570 D0 GB 0610570D0 GB 0610570 A GB0610570 A GB 0610570A GB 0610570 D0 GB0610570 D0 GB 0610570D0
Authority
GB
United Kingdom
Prior art keywords
novel formulation
formulation
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0610570.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Original Assignee
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo, Pliva Istrazivanje i Razvoj doo filed Critical Pliva Hrvatska doo
Priority to GBGB0610570.4A priority Critical patent/GB0610570D0/en
Publication of GB0610570D0 publication Critical patent/GB0610570D0/en
Priority to PCT/GB2007/001975 priority patent/WO2007138301A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
GBGB0610570.4A 2006-05-27 2006-05-27 Novel formulation Ceased GB0610570D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0610570.4A GB0610570D0 (en) 2006-05-27 2006-05-27 Novel formulation
PCT/GB2007/001975 WO2007138301A2 (en) 2006-05-27 2007-05-29 Novel formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0610570.4A GB0610570D0 (en) 2006-05-27 2006-05-27 Novel formulation

Publications (1)

Publication Number Publication Date
GB0610570D0 true GB0610570D0 (en) 2006-07-05

Family

ID=36687864

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0610570.4A Ceased GB0610570D0 (en) 2006-05-27 2006-05-27 Novel formulation

Country Status (2)

Country Link
GB (1) GB0610570D0 (en)
WO (1) WO2007138301A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002217373A1 (en) * 2002-01-03 2003-07-15 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
IN2003MU00504A (en) * 2003-06-05 2005-05-13 Alembic Ltd
US20050226923A1 (en) * 2004-04-07 2005-10-13 Gassert Chad M Venlafaxine compositions in the form of microtablets
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology

Also Published As

Publication number Publication date
WO2007138301A2 (en) 2007-12-06
WO2007138301A3 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
GB0608098D0 (en) Formulation
GB2435419B (en) Formulations
EP2046930A4 (en) Rhamnolipid-based formulations
GB0605780D0 (en) Formulations
GB0720716D0 (en) Novel formulation
ZA201004439B (en) Formulation
GB0618697D0 (en) Formulations
IL198651A0 (en) COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL
GB0607605D0 (en) Composition
GB0615108D0 (en) Novel formulations
GB0610336D0 (en) Formulations
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
GB0707463D0 (en) Formulation
GB0612809D0 (en) Formulation
GB0715723D0 (en) Formulation
GB0718404D0 (en) Formulations
GB0712972D0 (en) Formulation
ZA200807682B (en) Novel formulations
GB0610570D0 (en) Novel formulation
ZA200806951B (en) Homeopathy-based formulation
GB0720719D0 (en) Novel formulation
GB0611519D0 (en) Formulations
GB0623791D0 (en) Formulations
GB0603981D0 (en) Tissue-adhesive formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)